Interleukin (IL)-31 Activates Signal Transducer and Activator of Transcription (STAT)-1, STAT-5 and Extracellular Signal-regulated Kinase 1/2 and Down-regulates IL-12p40 Production in Activated Human Macrophages
Overview
Affiliations
Background: Interleukin-31 is a cytokine expressed by activated T cells. A major function of IL-31 in atopic dermatitis (AD) is the induction of pruritus in the skin. We recently showed that IL-31 induces pro-inflammatory cytokines following staphylococcal exotoxins' stimulation in human macrophages. However, signalling pathways of IL-31 in activated human macrophages still remain unclear. The aim of the study was to investigate the signalling pathways of IL-31 receptor as well as functional effects of IL-31 in activated macrophages.
Methods: Human macrophages were prestimulated with staphylococcal exotoxins (SEB, α-toxin) to up-regulate the IL-31 receptor with and without IL-31. Phospho-signal transducer and activator of transcription (pSTAT) 1/3/5, phospho-extracellular signal-regulated kinase (ERK 1/2), β-actin as well as p21/WAF/Cip1 levels were determined by means of Western blot analysis. Interleukin-12p40, IL-12p70 and IL-23 secretions were assessed by using an enzyme-linked immunosorbent assay.
Results: Interleukin-31 strongly activated STAT-1 and 5 but not STAT-3 in human macrophages after up-regulation of IL-31 receptor with staphylococcal exotoxins. p21/WAF/Cip1 expression was induced by IL-31 in activated human macrophages. Furthermore, IL-31 down-regulated. IL-12p40 secretion via ERK 1/2 phosphorylation in human macrophages following up-regulation of IL-31 receptor with staphylococcal exotoxins.
Conclusions: The T helper (Th) 2 cytokine IL-31 induces pro-inflammatory effects in activated human macrophages via STAT-1 and 5 phosphorylation. Interleukin-31-induced ERK 1/2 activation contributes to the underlying mechanism of Th1 cytokine IL-12 suppression in macrophages. This mechanism may be relevant in Th2 inflammatory responses and may help to develop therapeutic strategies in IL-31-associated diseases such as AD.
Role of skin-homing t-cells in recurrent episodes of atopic dermatitis: a review.
Guo H, Yuan H, Yu Y, Sun J, Sun Y, Tang Y Front Immunol. 2025; 16:1489277.
PMID: 40040698 PMC: 11876967. DOI: 10.3389/fimmu.2025.1489277.
Wu Y, Ran X, Li Q, Wu Y, Shen X, Mu M Transl Cancer Res. 2025; 14(1):424-433.
PMID: 39974413 PMC: 11833404. DOI: 10.21037/tcr-24-1306.
Yamamura Y, Nakashima C, Otsuka A Front Med (Lausanne). 2024; 11:1342176.
PMID: 38590314 PMC: 10999685. DOI: 10.3389/fmed.2024.1342176.
Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis.
Chiocchetti R, Salamanca G, Silva M, Gobbo F, Aspidi F, Zamith Cunha R Front Vet Sci. 2022; 9:987132.
PMID: 36187821 PMC: 9521433. DOI: 10.3389/fvets.2022.987132.
IL-31: State of the Art for an Inflammation-Oriented Interleukin.
Borgia F, Custurone P, Li Pomi F, Cordiano R, Alessandrello C, Gangemi S Int J Mol Sci. 2022; 23(12).
PMID: 35742951 PMC: 9223565. DOI: 10.3390/ijms23126507.